Carisoprodol is an FDA-approved drug indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions.  It has approval for up to three weeks of use only. Carisoprodol is not recommended for use in patients under the age of 16 since this medication has not been evaluated in the pediatric population. In the United States, it is a schedule IV controlled substance. First approved for medical use in the United States in 1959, carisoprodol is available as a generic medication. It comes in tablet form and can be taken by mouth up to three times a day and once before bed. According to the package insert, carisoprodol is intended to be used together with rest, physical therapy, and other measures to relax muscles after strains, sprains, and muscle injuries.